CTOs on the Move

BAROnova

www.baronova.com

 
BAROnova, Inc., founded in 2006 and based in Goleta, CA, is a clinical-stage medical-device company focused on developing non-surgical non-pharmacologic devices to induce weight loss.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.baronova.com
  • 281 Magnolia Ave Suite 300
    Goleta, CA USA 93117
  • Phone: 805.681.7000

Executives

Name Title Contact Details

Funding

BAROnova raised $36.5M on 11/23/2015

Similar Companies

Allpro Inc

Allpro Inc is a Broomfield, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ACell

ACell, Inc. is a leading regenerative medicine company focused on the development, manufacturing, and commercialization of unique proprietary extracellular matrix (ECM) products to facilitate the repair and remodeling of damaged tissues. ACell is committed to becoming and remaining an innovative leader in regenerative medical technology, offering superior healing options for doctors and patients. ACell is a privately held company and operates manufacturing facilities in Columbia, MD and Lafayette, IN.

Phoenix Bio-Tech Corp

Phoenix Bio-Tech Corp is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Trice Medical

Trice Medical was founded to fundamentally improve orthopedic diagnostics. Trice has pioneered fully integrated camera-enabled technologies that provide a clinical solution that is optimized for the physicians office. Our mission is to provide more immediate and definitive patient care, eliminating the false reads associated with current indirect modalities and significantly reduce the overall cost to the healthcare system.

Impel NeuroPharma

Impel NeuroPharma is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel has developed a novel drug delivery platform, the POD technology, that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. Impel`s proprietary (POD) device technology enables entirely new categories of drugs, including biologics, to be delivered to the central nervous system using a cost-effective, disposable, non-invasive intranasal drug delivery device.